Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Binding affinity to CK1a1L (unknown origin)
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
CSNK1A1L DiscoveRx kinase panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Inhibition of CK1a1L (unknown origin) at 1 uM
SummaryPubMed CitationRelated BioAssays by Target
KinomeScan assay: inhibition of CSNK1A1L
Assay data:108 Tested
CK1alpha2(C1ALLGI5) Takeda global kinase panel
Assay data:1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, activity ≤ 1 µMRelated BioAssays by Target
CSNK1A1L Invitrogen Lab (UK) kinase screen (BI)
Inhibition of CK1A1 (unknown origin) at 1000 nM relative to control
Assay data:2 Tested
Inhibition of human CSNK1A1L assessed as percent of control at 2000 nM by KINOMEscan assay relative to control
Inhibition of DNA-tagged human CSNK1A1L assessed as percent of control at 50000 nM by qPCR analysis relative to control
Inhibition of human CSNK1A1L assessed as percent of control at 1000 nM by KINOMEscan assay relative to control
Inhibition of wild-type human full length CSNK1A1L (M1 to N337 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control
Inhibition of CSNK1A1L (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control
Binding affinity to wild-type human full length CSNK1A1L (M1 to N337 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control
Inhibition of human partial length CSNK1A1L (M1 to N337 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by kinome scan method relative to control
Inhibition of CK1a1L (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control
Inhibition of human CK1a1L using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay
Inhibition of human CK1a1L assessed as residual activity using KRRRAL[pS]VASLPGL as substrate at 1 uM by [gamma-33P]-ATP assay relative to control
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on